EndoQuest raises $42M C-1 financing for endoluminal robotics
EndoQuest Robotics closed a $42 million C-1 financing to advance its flexible endoluminal robotic surgery platform.
Evidence notes
- The C-1 round was led by CE Ventures Limited and McNair Interests Ltd., with Puma Venture Capital joining as a new investor.
- EndoQuest said the capital would support technology development, regulatory progress and commercialization of its flexible robotic system.
Company context
EndoQuest Robotics develops a flexible endoluminal surgical robot for procedures performed through the body’s natural orifices. Founded in Houston as ColubrisMX and rebranded in 2022, the company combines steerable endoscopy with robotic instrument control for upper and lower gastrointestinal interventions. Its investigational ELS System is intended to enable precise, scar-free surgery without external incisions.